Company Valuation: Medical Net, Inc.

Data adjusted to current consolidation scope
Fiscal Period: May 2020 2021 2022 2023 2024 2025
Market Cap 1 1,980 5,558 4,108 3,555 3,329 2,852
Change - 180.76% -26.09% -13.47% -6.36% -14.31%
Enterprise Value (EV) 1 1,785 5,072 3,748 2,826 2,830 2,647
Change - 184.21% -26.11% -24.61% 0.14% -6.44%
P/E 26.6x 42.2x 10.6x 30.4x 666x -41.6x
PBR 1.99x 4.48x 2.41x 1.86x 1.75x 1.61x
PEG - 0.6x 0x -0.4x -7x 0x
Capitalization / Revenue 0.68x 1.67x 1.1x 0.79x 0.63x 0.47x
EV / Revenue 0.61x 1.52x 1x 0.63x 0.54x 0.44x
EV / EBITDA 14.3x 14.3x 7.83x 6.42x 8.04x 15.1x
EV / EBIT 16.8x 15.3x 8.33x 7.46x 9.46x 26.7x
EV / FCF 63.7x 15.4x 21.5x 7.6x 31.7x -16.5x
FCF Yield 1.57% 6.49% 4.66% 13.2% 3.15% -6.04%
Dividend per Share 2 0.75 2.5 2.5 2.5 3 3
Rate of return 0.31% 0.39% 0.54% 0.64% 0.82% 0.95%
EPS 2 9.214 15.28 43.88 12.95 0.5528 -7.62
Distribution rate 8.14% 16.4% 5.7% 19.3% 543% -39.4%
Net sales 1 2,917 3,330 3,745 4,500 5,252 6,077
EBITDA 1 125 355 479 440 352 175
EBIT 1 106 331 450 379 299 99
Net income 1 79 129 384 116 5 -68
Net Debt 1 -195 -486 -360 -729 -499 -205
Reference price 2 245.00 645.00 466.00 393.00 368.00 317.00
Nbr of stocks (in thousands) 8,081 8,618 8,816 9,045 9,045 8,998
Announcement Date 8/31/20 A 8/31/21 A 8/31/22 A 8/31/23 A 8/30/24 A 8/27/25 A
1JPY in Million2JPY
Estimates

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 14.24M
14.55x0.42x9.01x2.76% 123B
13.79x1.76x8.79x0.76% 88.53B
14.13x1.56x9.38x2.43% 30.3B
23.47x2.61x13.24x1.38% 26.32B
32.3x5.81x23.88x2.15% 21.85B
7.79x1.4x6.41x-.--% 20.66B
14.36x1.02x5.72x3.39% 12.79B
12.4x1.58x7.62x0.92% 11.52B
54.55x9.13x34.41x0.19% 10.98B
Average 20.82x 2.81x 13.16x 1.55% 34.6B
Weighted average by Cap. 16.91x 1.77x 10.73x 1.79%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Stocks
  3. 3645 Stock
  4. Valuation Medical Net, Inc.